Olanzapine-induced neutropenia.
Gajwani
P
P
Department of Psychiatry and Psychology, Cleveland Clinic Foundation, OH 44195, USA.
Tesar
G E
GE
D000328:Adult; D014150:Antipsychotic Agents / Q000009:adverse effects* / Q000627:therapeutic use; D001569:Benzodiazepines; D004305:Dose-Response Relationship, Drug; D004359:Drug Therapy, Combination; D006801:Humans; D016651:Lithium Carbonate / Q000009:adverse effects / Q000627:therapeutic use; D008297:Male; D009503:Neutropenia / Q000139:chemically induced* / Q000188:drug therapy; D000077152:Olanzapine; D010890:Pirenzepine / Q000009:adverse effects / Q000031:analogs & derivatives* / Q000627:therapeutic use; D012563:Schizophrenia, Paranoid / Q000188:drug therapy* / Q000523:psychology
D014150:Antipsychotic Agents; D001569:Benzodiazepines; D016651:Lithium Carbonate; D010890:Pirenzepine; D000077152:Olanzapine